PO.BCS01.06 · 生物信息与计算
通过数字病理学对直肠癌早期形态学放疗反应进行多尺度表征
Multiscale characterization of early morphologic radiation response in rectal cancer via digital pathology
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
通过有效的新辅助化疗和放疗(RT),部分局部区域性直肠癌患者可能避免手术。然而,患者的反应高度异质且理解不足。尽管形态学评估仍是临床金标准,但它往往受肿瘤丰度主导,可能忽略对治疗的复杂生物学适应。为解决这一问题,我们试图通过对RT后早期组织学变化进行多尺度表征来获得见解。我们利用来自INNATE试验数据集的配对RT前后组织学切片,以邻近组织作为对照,开发了一个双流程框架:(1)C-MorphQuant,用于基于微调的细胞分类器和训练的区域分类器分析预定义的经典特征,如组织组成、空间组织和核形态;以及(2)DL-RadScore,一种新颖的深度学习指标,通过区分照射与未照射组织从头学习形态学特征。我们的C-MorphQuant分析揭示:(1)在组成上,肿瘤和正常上皮明显减少,间质相应增加;(2)在空间上,腺体破坏为碎片化的小簇(<30个核);以及(3)在核层面,大小和形状发生了明显但因患者而异的改变。值得注意的是,虽然总体放射影响在肿瘤中通常更强,但C-MorphQuant表型比在邻近正常组织中观察到的典型适应更为异质。DL-RadScore能够准确区分未见过的放疗前后样本。我们通过与肿瘤上皮Ki67增殖进行比较确立了生物学相关性,发现在患者水平(r = -0.59,p = 2.08*10-2)和切片内水平(r = -0.43,p = 2.17*10-78)均存在强负相关。虽然DL-RadScore与C-MorphQuant组成指标保持强一致性,但它在捕捉增殖状态方面优于肿瘤细胞密度指标。最引人注目的是,我们的结果表明,一些肿瘤并非逐渐累积形态学变化,而是最初似乎“甩掉”了早期放射剂量,保持了类似治疗前的形态,但最终在手术时崩溃。总之,本研究强调了在单纯肿瘤细胞丰度之外表征治疗诱导表型的价值,并凸显了复杂的非线性时空动态,即早期形态学持续存在并不排除长期治愈。
查看英文原文 English abstract
With effective neoadjuvant chemotherapy and radiotherapy (RT), some patients with locoregional rectal cancer may avoid surgery. However, patient responses are highly heterogeneous and poorly understood. Although morphological assessment remains the clinical gold standard, it is often dominated by tumor abundance, potentially overlooking complex biological adaptations to treatment. To address this, we sought to gain insights through a multiscale characterization of early histologic changes following RT. We leveraged matched pre- and post-RT histology slides from the INNATE trial dataset, using adjacent tissue as a control, to develop a dual-pipeline framework: (1) C-MorphQuant, for analysis of predefined classical features such as tissue composition, spatial organization, and nuclear morphology based on a finetuned cell classifier and a trained region classifier; and (2) DL-RadScore, a novel deep learning metric that learns de novo morphological features by distinguishing irradiated from non-irradiated tissue. Our C-MorphQuant analysis revealed: (1) compositionally, a clear reduction in tumor and normal epithelium with a commensurate increase in stroma; (2) spatially, the disruption of glands into fragmented small clusters (<30 nuclei); and (3) nuclearly, alterations in size and shape that were evident but patient-specific. Notably, while the overall radiation impact was generally stronger in tumor, C-MorphQuant phenotypes were more heterogeneous than the stereotypical adaptations observed in adjacent normal tissue. The DL-RadScore accurately distinguished unseen pre- and post-radiation samples. We established biological relevance by comparing with tumor epithelial Ki67 proliferation and found strong negative correlations at both the patient (r = -0.59, p = 2.08*10 -2 ) and intra-slide (r = -0.43, p = 2.17*10 -78 ) levels. While DL-RadScore maintained strong concordance with C-MorphQuant composition metrics, it outperformed measures of tumor cellularity in capturing proliferative status. Most intriguingly, our results demonstrated that rather than a gradual accumulation of morphological changes, some tumors appeared to initially "shrug off" early radiation doses, preserving a pre-treatment-like morphology, yet ultimately collapsed by the time of surgery. In summary, this study underscores the value of characterizing treatment-induced phenotypes beyond mere tumor cell abundance and highlights the complex non-linear spatiotemporal dynamics in which early morphological persistence does not preclude long-term cure.
利益披露 Disclosure
S. Veerapaneni, None..
P. Acosta, None..
B. Dawod, None..
S. Diegeler, None..
M. Yu, None.
E. Elghonaimy,
ALPA Biosciences Stock.
M. Wachsmann, None..
P. Gopal, None.
T. Aguilera,
ALPA Biosciences g., Board of Directors, non-salaried role).
Novocure Other, Advisory Board.
Renovo Rx. Travel.
Avelas Biosciences Stock.
S. Rajaram, None.